Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1997-05-16
1999-10-05
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514570, A61K 3120
Patent
active
059625279
ABSTRACT:
A composition and method of preventing or inhibiting tumor growth, and of treating malignant cancers without toxic side effects are disclosed. Betulinic acid or a betulinic acid derivative is the active compound of the composition.
REFERENCES:
patent: 5468888 (1995-11-01), Bouboutou et al.
Batta et al., "Crystalline chemical components of some vegetable drugs," Phytochemistry, 12, 214-16 (1973).
Otsuka et al., "Studies on anti-inflammatory agents. V. A new anti-inflammatory constituent of Pyrancantha crenulata roem.," Chem. Pharm. Bull. (Tokyo), 29(11), (Nov., 1981).
Konoshima et al., "Studies on inhibitors of skin-tumor promotion, I. Inhibitory effects of triterpenes from Euptelea polyandra on Epstein-Barr virus activation," J. Nat. Prod., 1167-70 (1987).
Rajaram et al., "Constituents of the roots of Diospyros chloroxylon Roxb," Indian Drugs, 25, 211-12 (1988).
Patent Abstracts of Japan, vol. 013, No. 399, (Sep. 1989).
Ryu et al., "Antitumor triterpenes from medicinal plants," Archives of Pharm. Research (Seoul), 17(5), 375-377 (1994).
Fujioka et al., "Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids," J. Nat. Prod., 57, 243-7 (1994).
"News and features. II," Faseb Journal, vol. 9, No. 8, 573 (May 1995).
Pisha et al., "Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis," Nat. Med., 1(10), pp. 1046-51, (Oct., 1995).
Yasukawa et al., "Some lupane-type triterpenes inhibit tumor promotion by 12-0-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin," Phytomedicine, 309-13 (1995).
Del Carmen et al., "Structural requirements for the anti-inflammatory activity of natural triterpenoids," Planta Medica, 61/2, 182-185 (1995).
Kashiwada et al., "Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents," J. Med. Chem., 39, 1016-17 (1996).
"Natural substances in the treatment of melanoma," Munchener Medizinische Wochenschrift, 138/7 (18) (1996).
Nagourney et al., "Preliminary analysis of betulinic acid in human tumor primary cultures (meeting abstract)," Proc. Annu. Meet. Am. Assoc. Cancer Res., 37:A2724 (1996).
Evers et al., "Betulinic acid derivatives: A new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action," J. Med. Chem., 39, 1056-68 (1996).
Bogenrieder et al., "Analysis of pentacyclic triterpene-mediated antiproliferative effects on malignant melanoma cells (Meeting abstract)," Proc. Annu. Meet. Am. Assoc. Cancer Res., 38:A1458 (1997).
Manez et al., "Effect of selected triterpenoids on chronic dermal inflammation," European Journal of Pharmacology, vol. 334, No. 1, 103-105 (Sep., 1997).
Ryo et al, Arch. Pharmacol. Res., 17 (1) pp. 375-377, 1994.
Sheth et al, J. Pharm. Sci. 61(11), 1819, 1972.
"Carcinostatics contg. betulin derivs.--having excellent antioncotic activities with less side effects," Chemical Abstracts, 89-204083/28, Dec. 1987.
Maurya et al., "Content of betulin and betulinic acid, antitumor agents of Zizyphus species," Fitoterapia, IX, No. 5, pp. 468-469, 1989.
Abstract No. 2724, International Symposium on Advances in Neuroblastoma Research, Meeting Dates--May 22-25, 1996.
Yasukawa et al., "Sterol and triterpene derivatives from plants inhibit the effects of a tumor promoter, and sitosterol and betulinic acid inhibit tumor formation in mouse skin two-stage carcinogenesis," Oncology, 48, pp. 72-76, 1991.
DasGupta Tapas K.
Kim Darrick S. H. L.
Kuzmanoff Konrad Marc
Ling-Indeck Lydia
Pezzuto John M.
Goldberg Jerome D.
The Board of Trustees of the University of Illinois
LandOfFree
Method and composition for treating cancers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for treating cancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for treating cancers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1172193